Jennifer Crombie, MD, Dana-Farber Cancer Institute, Boston, Massachusetts, discusses results from a real-world study of lisocabtagene maraleucel in patients with relapsed/refractory large B-cell lymphoma. Similar to published findings…
Tanya Siddiqi, MD, medical director of lymphoma, City of Hope, Orange County, California, discusses the primary analysis of the TRANSCEND CLL 004 trial. This phase 1/2, single-arm, multicenter…
NEW YORK (Reuters Health) – Long-term adjuvant therapy with pegylated interferon alfa-2b (PEG-IFN-alpha-2b) for advanced melanoma improves recurrence-free survival, investigators report in an early online release from the…
NEW YORK (Reuters Health) – Using a new approach to detect tumor-associated plasma proteins, Canadian researchers have discovered a novel biomarker that may improve the diagnosis of lung…
Kim Hunter-Schaedle, PhD, Chief Scientific Officer of the Children’s Tumor Foundation, discusses the role of the CTF in education and research of neurofibromatosis, a disorder of tumor suppressors.…
NEW YORK (Reuters Health) Women with long-standing hypothyroidism are at increased risk of hepatocellular carcinoma, the results of a case-control study suggest. By contrast, hypothyroidism is not significantly…
NEW YORK (Reuters Health) – Breast cancers that are ER/PR negative and HER-2/neu nonamplified are more likely than those without triple negative status to show a complete pathologic…
NEW YORK (Reuters Health) – The presence of multiple single nucleotide polymorphisms (SNPs) associated with increased prostate cancer risk, coupled with a positive family history, accurately identify men…
NEW YORK (Reuters Health) – High urinary levels of a carcinogen in tobacco may help predict risk of lung cancer in smokers, according to research reported at the…
NEW YORK (Reuters Health) – Overall, women who were treated for cancer during childhood are about 20% less likely to become pregnant than their unaffected sisters, according to…
NEW YORK (Reuters Health) – Stereotactic body radiation therapy (SBRT) for early-stage non-small-cell lung cancer (NSCLC) results in “excellent 3-year local control and survival rates,” researchers report based…
NEW YORK (Reuters Health) – Although folate fortification of foods may reduce the rate of neural tube defects in target populations, new research from Chile suggests that it…
